SCHEMBL9301168

SCHEMBL9301168

Nc1cc(COCCCS(=O)(=O)O)cc(Nc2c3ccccc3nc3ccccc23)c1

nearest known ligand 0.63

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
TOP2A P11388 10/20 0.63
TOP2B Q02880 9/20 0.63
KDM1A O60341 3/20 0.45
CYP1A2 P05177 1/20 0.45
CYP2D6 P10635 1/20 0.45
CYP2C9 P11712 1/20 0.45
CASP1 P29466 1/20 0.45
CASP7 P55210 1/20 0.45
L3MBTL1 Q9Y468 1/20 0.43
RAD52 P43351 3/20 0.43
POLB P06746 2/20 0.43
MEN1 O00255 1/20 0.43
GFER P55789 1/20 0.43
KMT2A Q03164 1/20 0.43
ATM Q13315 1/20 0.42
HDAC3 O15379 1/20 0.41
HDAC4 P56524 1/20 0.41
HDAC1 Q13547 1/20 0.41
HDAC7 Q8WUI4 1/20 0.41
HDAC2 Q92769 1/20 0.41

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL9300746 0.99 TOP2A (0.61) TOP2ATOP2BKDM1ACYP1A2CYP2D6
SCHEMBL9300987 0.94 TOP2A (0.63) TOP2ATOP2BKDM1ACYP1A2CYP2D6
SCHEMBL9300780 0.92 TOP2A (0.61) TOP2ATOP2BKDM1ACYP1A2CYP2D6
SCHEMBL9300742 0.90 TOP2A (0.57) TOP2ATOP2BKDM1ACYP1A2CYP2D6
SCHEMBL9300856 0.90 TOP2A (0.59) TOP2ATOP2BKDM1ACYP1A2CYP2D6
SCHEMBL9301299 0.88 TOP2A (0.62) TOP2ATOP2BKDM1ACYP1A2CYP2D6
SCHEMBL9299561 0.86 TOP2A (0.60) TOP2ATOP2BKDM1ACYP1A2CYP2D6
SCHEMBL9300978 0.86 TOP2A (0.58) TOP2ATOP2BKDM1ACYP1A2CYP2D6
SCHEMBL9300850 0.85 TOP2A (0.59) TOP2ATOP2BKDM1ACYP1A2CYP2D6
SCHEMBL9300948 0.85 TOP2A (0.56) TOP2ATOP2BKDM1ACYP1A2CYP2D6

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-5354864-A Antitumor agents SLOAN-KETTERING INSTITUTE FOR CANCER RESEARCH (US) 1994-10-11 US claimed
WO-1993023049-A1 3-(9-ACRIDINYLAMINO)-5-HYDROXYMETHYLANILINE DERIVATIVES AS ANTICANCER AGENTS SLOAN-KETTERING INSTITUTE FOR CANCER RESEARCH (US) 1993-11-25 WO claimed